Insmed (INSM) EBT (2010 - 2026)
Insmed (INSM) recorded quarterly EBT of -$162.1 million in Q1 2026, up 50.42% quarter-over-quarter from -$326.9 million in Q4 2025, and up 36.6% on a YoY basis from -$118.7 million in Q1 2025.
Insmed (INSM) EBT (2010 - 2026) Analysis & Trends
Insmed's EBT history runs 17 years deep, the most recent figure standing at -$162.1 million for Q1 2026.
- In Q1 2026, EBT rose 36.6% year-over-year to -$162.1 million; the TTM figure through Mar 2026 stood at -$1.2 billion (down 16.74% YoY), while the FY2025 annual figure was -$1.3 billion, down 39.74% from the prior year.
- EBT was -$162.1 million for Q1 2026 at Insmed, up from -$326.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$94.2 million in Q1 2022 to a low of -$368.7 million in Q3 2025.
- Historically, EBT has averaged -$210.1 million across 5 years, with a median of -$185.1 million in 2023.
- The sharpest annual moves came in 2023 and 2026: EBT slumped 156.75% in 2023, then soared 36.6% in 2026.
- A 5-year view of EBT shows it stood at -$160.0 million in 2022, then decreased by 15.67% to -$185.1 million in 2023, then slipped by 26.6% to -$234.3 million in 2024, then sank by 39.55% to -$326.9 million in 2025, then jumped by 50.42% to -$162.1 million in 2026.
- The last three EBT figures came in at -$162.1 million (Q1 2026), -$326.9 million (Q4 2025), and -$368.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -56.48 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -162.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162.10 Mn |
| Dec 31, 2025 | -326.93 Mn |
| Sep 30, 2025 | -368.70 Mn |
| Jun 30, 2025 | -320.44 Mn |
| Mar 31, 2025 | -255.67 Mn |
| Dec 31, 2024 | -234.28 Mn |
| Sep 30, 2024 | -219.51 Mn |
| Jun 30, 2024 | -299.77 Mn |
| Mar 31, 2024 | -156.50 Mn |
| Dec 31, 2023 | -185.06 Mn |
| Sep 30, 2023 | -158.39 Mn |
| Jun 30, 2023 | -244.28 Mn |
| Mar 31, 2023 | -159.28 Mn |
| Dec 31, 2022 | -160.00 Mn |
| Sep 30, 2022 | -130.77 Mn |
| Jun 30, 2022 | -95.14 Mn |
| Mar 31, 2022 | -94.24 Mn |
| Dec 31, 2021 | -113.02 Mn |
| Sep 30, 2021 | -115.29 Mn |
| Jun 30, 2021 | -116.70 Mn |